Critical Therapeutics, Inc. Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma Holdings, Inc. and 10-to-1 Reverse Stock Split.
Business Wire (October 31, 2008)
Permanent Link:
http://vlex.com/vid/stockholder-approvals-cornerstone-biopharma-56130495
Id. vLex: VLEX-56130495
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Business
Business, general
Biological products industry
Stocks
Company acquisition/merger
Mergers, acquisitions and divestments
Critical Therapeutics, Inc. Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma Holdings, Inc. and 10-to-1 Reverse Stock Split.
LEXINGTON, Mass. -- Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that its stockholders voted this morning to approve (1) the issuance of Critical Therapeutics' common stock pursuant to the Agreement and Plan of Merger, dated as of May 1, 2008...
Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
